Margaret R Belongy, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Sara Grace Kunz Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 N 64th St, Belleville, IL 62223 Phone: 618-397-8400 |
Julie Malherek, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1306 Wabash Ave, Belleville, IL 62220 Phone: 618-234-6876 Fax: 618-234-6150 |
Ms. Rudaba Khalid, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Frank Scott Pkwy W, Belleville, IL 62223 Phone: 618-607-5103 Fax: 618-641-5814 |
Brefeld Physical Therapy Services Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 106 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-236-7588 Fax: 618-236-7589 |
Amy Shevlin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Mr. Donald Clay Courtial, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Rehabilitation Services Momorial Hospital, 4500 Memorial Drive, Belleville, IL 62226 Phone: 618-257-5254 Fax: 618-257-6929 |
Chelsie Klieber, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Frank Scott Pkwy W Ste 984, Belleville, IL 62223 Phone: 618-235-8565 |
Doris A Thole, PT Physical Therapist - Geriatrics Medicare: Not Enrolled in Medicare Practice Location: 1021 W E St, Belleville, IL 62220 Phone: 618-233-2095 |
Jessica Marie Roth Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1021 W E St, Belleville, IL 62220 Phone: 618-233-2095 |
Laura A Shimkus, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Frank Scott Pkwy W Ste 928, Belleville, IL 62223 Phone: 618-234-9705 |
Ashlee D Sandstrom, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Andrea H Koehler, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Mrs. Deborah Jean Schneider, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4500 Memorial Drive, Belleville, IL 62226 Phone: 618-257-5250 |
Laura R Gaubatz, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Shane Recer Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 144 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-233-5163 Fax: 618-233-5164 |
Empowerme Wellness Kansas City, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 1021 W E St, Belleville, IL 62220 Phone: 844-502-7996 |
Autumn M Barnett, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1915 Carlyle Ave Ste D, Belleville, IL 62221 Phone: 618-310-0305 |
Erin D Huebner, P. T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
Candee Krueger, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705 Fax: 618-257-0665 |
News Archive
Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.
Pfizer Inc. today announced that the ORAL Sync Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints by showing statistically significant changes versus placebo in reducing signs and symptoms of RA, as measured by ACR20 response rates at six months; in improving physical function, as measured by mean change in HAQ DI at three months; and in reaching DAS28-4 <2.6 at six months.
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.
Researchers at the University at Buffalo have discovered how mutations in the parkin gene cause Parkinson's disease, which afflicts at least 500,000 Americans and for which there is no cure. The results are published in the current issue of Nature Communications.
› Verified 9 days ago